Hoboken, NJ, United States of America

Michael Sofolarides


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Sofolarides: Innovator in Inflammatory Disorder Treatments

Introduction

Michael Sofolarides is a notable inventor based in Hoboken, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory disorders. His innovative work has the potential to improve the lives of many individuals suffering from various health conditions.

Latest Patents

Sofolarides holds a patent for "Fused tricyclic compounds for the treatment of inflammatory disorders." This invention relates to certain lactam ring-containing compounds and their pharmaceutically acceptable salts. The patent outlines methods for using these compounds to treat or prevent inflammatory disorders such as rheumatoid arthritis, inflammatory bowel disease, psoriasis, asthma, and chronic obstructive pulmonary disorder. He has 1 patent to his name.

Career Highlights

Michael Sofolarides is currently employed at Merck Sharp & Dohme Corporation, a leading global healthcare company. His role involves research and development focused on innovative treatments for various medical conditions. His expertise and dedication to advancing pharmaceutical science have made him a valuable asset to his team.

Collaborations

Throughout his career, Sofolarides has collaborated with talented professionals, including Dong Xiao and Anandan Palani. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Michael Sofolarides is a distinguished inventor whose work in developing treatments for inflammatory disorders showcases his commitment to improving healthcare. His contributions to the field are noteworthy and have the potential to make a significant impact on patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…